Remove Conditions Remove Data Remove Epilepsy Remove Programs
article thumbnail

Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting

Cannabis Law Report

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

article thumbnail

States That Restrict MMJ Access Are Interfering With Patients’ Rights, Study Shows

Veriheal

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.

Access 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PA: Court orders release on medical cannabis data regarding, “how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment.”

Cannabis Law Report

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.

Data 52
article thumbnail

Revamping Texas’ Medical Cannabis Program Is the Key to Ending the State’s Opioid Crisis

Veriheal

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. According to Dr. Haider Warraich , interdisciplinary pain rehabilitation programs that combine therapy with medication are considered the gold standard of chronic pain care.

article thumbnail

Tyson and Holyfield Announce Edibles, Texas’ Medical Cannabis Gains, and Big Hemp Study

Veriheal

A pair of boxing legends teamed up for an unexpected collaboration, Texas’ medical cannabis program saw big gains, and a hemp study revealed troubling signs for the industry. Texas’ Medical Cannabis Program Sees Growth Despite Limitations. Further, the state only has three dispensing organizations to serve its growing program.

Edibles 97
article thumbnail

Cloud-based Software Could Fuel Growth of South Dakota’s Medical Cannabis Program

Veriheal

cloudPWR , a pioneer in cloud software for enterprise businesses and government agencies, is collaborating with fellow cloud-based solutions leader Accela to provide the South Dakota Department of Health (SDDOH) with an on-demand computer system-operated medical cannabis program registry. Epilepsy and seizures. Multiple sclerosis.

article thumbnail

Renewing Medical Marijuana Cards in Arkansas: All You Need to Know

MMJ Recs

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.